Some receive a little, but what they may be taught is not necessarily up to date or their training focused solely on PA (pernicious anaemia) and the frankly ridiculous notion that anyone without a definite diagnosis of this or the presence of anaemia does not require treatment
Covers AMPK activation, glucose metabolism, aging research, dosing, and preclinical findings
ISSN 1469-493X
It's a selective NNMT inhibitor that preserves your NAD+ pool, reactivates sirtuin signaling, and suppresses fat storage all without touching your appetite
AOD9604 is studied for stimulating fat breakdown specifically, without the bone growth, muscle growth, or insulin resistance effects typically associated with full-length growth hormone administration
The logic is solid, though it's worth noting this is a community-derived protocol, not a studied stack